DSE : SILVAPHL

Silva Pharmaceuticals Limited — Financial statements

Pharmaceutical Preparations · Bangladesh

Last price 10.3 BDT (At close: Oct 29, 2026) · Market cap 1.41B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Technical report: trend, RSI, support and resistance, charts

Financial statements

Silva Pharmaceuticals Limited (SILVAPHL) reported revenue of 329.63M BDT (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue329.63M383.65M599.66M716.87M778.67M799.25M
Cost of Revenue244.19M283.13M437.91M487.58M492.89M486.26M
Gross Profit85.44M100.51M161.75M229.29M285.78M312.99M
Selling, General & Admin227.29M221.52M209.99M185.61M175.07M171.85M
Other Operating Expenses-1.10M-1.05M-939.62K
Operating Expenses227.29M221.52M209.99M184.51M174.02M170.91M
Operating Income-141.85M-121.01M-48.25M44.78M111.76M142.09M
Interest Expense-3.67M-4.48M-4.38M-3.61M-4.71M-2.78M
Interest & Investment Income3.58M5.34M5.17M9.45M9.67M12.05M
Other Non Operating Income (Expenses)170.42K575.16K964.42K-258.44K-48.71K-15.99K
Pretax Income-141.76M-119.58M-46.50M50.36M116.67M151.35M
Income Tax Expense12.42M13.37M17.99M17.29M14.41M31.49M
Net Income-154.19M-132.95M-64.48M33.08M102.26M119.85M
Net Income to Common-154.19M-132.95M-64.48M33.08M102.26M119.85M
Shares Outstanding (Basic)136.50M136.50M136.50M136.50M136.50M136.50M
Shares Outstanding (Diluted)136.50M136.50M136.50M136.50M136.50M136.50M
EPS (Basic)-1.13-0.97-0.470.240.750.88
EPS (Diluted)-1.13-0.97-0.470.240.750.88
Free Cash Flow-13.93M6.49M-29.57M-16.70M-16.80M82.22M
Free Cash Flow Per Share-0.100.05-0.22-0.12-0.120.60
Dividend Per Share0.100.100.300.50
Gross Margin25.92%26.20%26.97%31.99%36.70%39.16%
Operating Margin-43.03%-31.54%-8.05%6.25%14.35%17.78%
Profit Margin-46.78%-34.65%-10.75%4.61%13.13%15.00%
Free Cash Flow Margin-4.23%1.69%-4.93%-2.33%-2.16%10.29%
EBITDA-88.24M-63.18M10.54M107.29M174.33M207.38M
EBITDA Margin-26.77%-16.47%1.76%14.97%22.39%25.95%
D&A For EBITDA53.60M57.83M58.79M62.51M62.57M65.29M
EBIT-141.85M-121.01M-48.25M44.78M111.76M142.09M
EBIT Margin-43.03%-31.54%-8.05%6.25%14.35%17.78%
Effective Tax Rate34.33%12.35%20.81%
Advertising Expenses5.37M3.82M3.81M5.92M20.65M

Balance sheet

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents83.80M38.77M38.69M28.64M36.43M58.66M
Short-Term Investments64.03M88.80M152.72M225.04M211.67M
Cash & Short-Term Investments83.80M102.80M127.49M181.37M261.47M270.33M
Accounts Receivable194.35M229.47M255.72M257.35M255.05M269.91M
Other Receivables143.44K411.59K1.97M2.56M2.30M
Receivables194.35M229.62M256.13M259.32M257.61M272.21M
Inventory406.95M443.01M493.20M493.72M482.29M464.18M
Other Current Assets62.94M54.40M62.69M66.02M61.79M68.21M
Total Current Assets748.03M829.84M939.52M1.00B1.06B1.07B
Property, Plant & Equipment1.38B1.42B1.47B1.50B1.48B1.37B
Other Intangible Assets2.24M2.42M1.22M1.36M1.51M1.68M
Total Assets2.13B2.25B2.41B2.50B2.54B2.45B
Accounts Payable14.31M9.97M7.16M6.99M6.90M6.25M
Accrued Expenses10.15M9.76M11.85M12.43M16.25M15.28M
Short-Term Debt28.22M47.71M55.84M91.01M29.14M
Current Portion of Leases1.01M1.07M1.18M1.42M2.34M5.67M
Current Income Taxes Payable9.74M6.47M5.45M7.90M19.03M30.63M
Other Current Liabilities96.69K207.98K817.56K1.62M2.59M1.52M
Total Current Liabilities35.30M55.70M74.16M86.19M138.11M88.48M
Long-Term Leases1.44M2.31M3.44M4.60M5.75M7.90M
Long-Term Deferred Tax Liabilities81.02M81.27M80.68M77.86M75.68M80.30M
Total Liabilities117.76M139.28M158.28M168.65M219.54M176.68M
Common Stock1.36B1.36B1.36B1.36B1.36B1.36B
Retained Earnings649.13M748.04M890.95M969.08M960.20M905.47M
Shareholders' Equity2.01B2.11B2.26B2.33B2.33B2.27B
Total Liabilities & Equity2.13B2.25B2.41B2.50B2.54B2.45B
Total Debt2.45M31.60M52.33M61.86M99.09M42.71M
Net Cash (Debt)81.35M71.21M75.17M119.51M162.38M227.62M
Net Cash Per Share0.600.520.550.881.191.67
Filing Date Shares Outstanding136.50M136.50M136.50M136.50M136.50M136.50M
Total Common Shares Outstanding136.50M136.50M136.50M136.50M136.50M136.50M
Working Capital712.73M774.14M865.35M914.23M925.05M986.45M
Book Value Per Share14.7615.4816.5317.1017.0316.63
Tangible Book Value2.01B2.11B2.25B2.33B2.32B2.27B
Tangible Book Value Per Share14.7415.4616.5217.0917.0216.62
Land342.77M342.77M342.77M342.77M342.77M342.77M
Buildings424.09M424.09M424.09M424.09M424.09M424.09M
Machinery1.15B1.15B1.15B1.09B1.07B998.72M
Construction In Progress324.86M323.28M317.67M343.47M274.25M178.47M

Cash flow statement

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-154.19M-132.95M-64.48M33.08M102.26M119.85M
Depreciation & Amortization54.83M59.11M60.45M65.93M68.12M70.73M
Other Amortization280.67K190.90K136.07K151.19K167.99K162.44K
Other Operating Activities7.16M8.77M7.06M-1.86M-11.12M3.29M
Change in Accounts Receivable52.61M26.51M3.19M-1.71M14.60M-8.79M
Change in Inventory39.69M50.19M520.39K-11.43M-18.11M-19.80M
Change in Accounts Payable5.97M2.81M173.55K94.13K641.54K-288.99K
Change in Other Net Operating Assets-16.72M-1.07M-3.63M-14.15M4.30M-5.76M
Operating Cash Flow-10.36M13.56M3.42M70.10M160.85M159.40M
Capital Expenditures-3.57M-7.07M-32.99M-86.81M-177.64M-77.18M
Investment in Securities83.91M24.77M63.92M72.32M-13.38M-8.63M
Investing Cash Flow80.34M17.70M30.93M-14.49M-191.02M-85.82M
Short-Term Debt Issued61.87M2.46M
Total Debt Issued61.87M2.46M
Short-Term Debt Repaid-19.49M-8.13M-35.17M
Long-Term Debt Repaid-1.70M-2.24M-3.20M-6.18M-6.49M
Lease Payments-1.59M-1.70M-2.24M-3.20M-6.18M-6.49M
Total Debt Repaid-39.39M-21.19M-10.37M-38.37M-6.18M-6.49M
Net Debt Issued (Repaid)-39.39M-21.19M-10.37M-38.37M55.69M-4.04M
Common Dividends Paid-3.32M-9.99M-13.93M-25.03M-47.75M-47.30M
Financing Cash Flow-42.71M-31.18M-24.30M-63.40M7.94M-51.34M
Net Cash Flow27.26M80.43K10.05M-7.78M-22.24M22.25M
Free Cash Flow-13.93M6.49M-29.57M-16.70M-16.80M82.22M
Free Cash Flow Margin-4.23%1.69%-4.93%-2.33%-2.16%10.29%
Free Cash Flow Per Share-0.100.05-0.22-0.12-0.120.60
Levered Free Cash Flow48.88M59.92M-1.92M-28.20M-48.45M53.24M
Unlevered Free Cash Flow51.18M62.73M817.32K-25.94M-45.50M54.98M
Free Cash Flow After Leases-15.53M4.79M-31.81M-19.91M-22.98M75.72M
Cash Interest Paid3.44M4.11M3.63M2.73M4.06M1.74M
Cash Income Tax Paid5.63M5.06M11.76M20.28M26.23M29.26M
Change in Working Capital81.55M78.44M256.09K-27.19M1.43M-34.63M

Ratios

Fiscal year July - June; amounts in BDT.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.41B1.46B1.95B2.95B3.29B2.69B
Enterprise Value1.32B1.36B1.82B2.81B3.13B2.48B
Last Close Price10.3010.7014.1621.2923.4218.63
PE Ratio89.1432.1722.44
PS Ratio4.273.813.254.114.223.36
PB Ratio0.700.690.861.261.421.18
P/TBV Ratio0.700.690.871.261.421.19
P/FCF Ratio225.0732.71
P/OCF Ratio107.73570.9442.0620.4516.87
EV/Sales Ratio4.023.553.043.924.023.10
EV/EBITDA Ratio172.7026.2217.9611.96
EV/EBIT Ratio62.8128.0217.45
EV/FCF Ratio209.8230.16
Debt / Equity Ratio0.000.010.020.030.040.02
Debt / EBITDA Ratio4.290.560.550.20
Debt / FCF Ratio4.870.52
Net Debt / Equity Ratio-0.04-0.03-0.03-0.05-0.07-0.10
Net Debt / EBITDA Ratio0.921.13-7.13-1.11-0.93-1.10
Net Debt / FCF Ratio5.84-10.972.547.159.67-2.77
Asset Turnover0.150.160.240.280.310.33
Inventory Turnover0.570.600.891.001.041.07
Quick Ratio7.885.975.175.113.766.13
Current Ratio21.1914.9012.6711.617.7012.15
Return on Equity (ROE)-7.37%-6.09%-2.81%1.42%4.45%5.36%
Return on Assets (ROA)-3.98%-3.24%-1.23%1.11%2.80%3.62%
Return on Invested Capital (ROIC)-7.28%-5.73%-2.20%1.34%4.66%5.56%
Return on Capital Employed (ROCE)-6.80%-5.50%-2.10%1.90%4.60%6.00%
Earnings Yield-10.97%-9.10%-3.30%1.12%3.11%4.46%
FCF Yield-0.99%0.44%-1.52%-0.57%-0.51%3.06%
Dividend Yield0.10%0.70%0.46%1.24%2.54%
Payout Ratio75.66%46.70%39.46%
Total Shareholder Return0.10%0.70%0.46%1.24%2.54%